Community and personal risk factors for hepatitis C virus infection: A survey of 23 820 residents in Taiwan in 1991-2

Gut

Volumn 60, Issue 5, 2011, Pages 688-694

  Lee, Mei Hsuan ^a   Yang, Hwai I ^a   Jen, Chin Lan ^a   Lu, Sheng Nan ^b   Yeh, Shiou Hwei ^c   Liu, Chun Jen ^d   You, San Lin ^a   Sun, Chien An ^e   Wang, Li Yu ^f   Chen, Wei J ^c   Chen, Chien Jen ^a,c  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; COMMUNITY; EDUCATION; FEMALE; GENDER; GENOTYPE; HEALTH SURVEY; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE; SEROPREVALENCE; TAIWAN;

ADULT; AGE DISTRIBUTION; AGED; COMMUNITY-ACQUIRED INFECTIONS; EPIDEMIOLOGIC METHODS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SEX DISTRIBUTION; TAIWAN; VIREMIA;

EID: 79953761239     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.220889     Document Type: Article

References (45)

1. Hutin Y, Kitler ME, Dore GJ, et al. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004;44:20-9. (Pubitemid 38005090)
2. Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:S35-S50. (Pubitemid 39423368)
3. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-44.
4. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007;96:1127-34. (Pubitemid 46608308)
5. Chien YC, Jan CF, Kuo HS, et al. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006;28:126-35.
6. Lu SN, Su WW, Yang SS, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006;119:1946-52.
7. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-67. (Pubitemid 41196755)
8. Dusheiko G, Schmilovitzweiss H, Brown D, et al. Hepatitis C virus genotypes an investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-18. (Pubitemid 24020465)
9. Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, et al. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. J Viral Hepat 1999;6:435-43.
10. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-14.
11. Perez CM, Suarez E, Torres EA, et al. Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. Int J Epidemiol 2005;34:593-9. (Pubitemid 40852575)
12. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol 2010;82:546-55.
13. Wang CS, Chang TT, Chou P. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan. J Clin Epidemiol 1998;51:733-8. (Pubitemid 28438677)
14. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999;59:290-6.
15. Chowdhury A, Santra A, Chaudhuri S, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003;37:802-9. (Pubitemid 36397391)
16. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [see comment]. N Engl J Med 1999;341:556-62.
17. Chang HC, Yu MW, Lu CF, et al. Risk factors associated with hepatitis C virus infection in Taiwanese government employees. Epidemiol Infect 2001;126:291-9. (Pubitemid 32454742)
18. Mujeeb SA, Shahab S, Hyder AA. Geographical display of health information: study of hepatitis C infection in Karachi, Pakistan [erratum appears in Public Health 2001 Jan; 115(1):82]. Public Health 2000;114:413-15.
19. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20:1-16. (Pubitemid 30421405)
20. Ansaldi F, Bruzzone B, Salmaso S, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis c virus infection in Italy. J Med Virol 2005;76:327-32. (Pubitemid 40770887)
21. Dubois F, Desenclos JC, Mariotte N, et al. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 1997;25:1490-6.
22. Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997;26:1006-11. (Pubitemid 27413671)
23. McMahon BJ, Hennessy TW, Christensen C, et al. Epidemiology and risk factors for hepatitis C in Alaska natives. Hepatology 2004;39:325-32. (Pubitemid 38222173)
24. Lee MH, Yang HI, Lu SN, et al. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. J Clin Oncol 2010;28:4587-93.
25. Sun CA, Chen HC, Lu SN, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001;65:30-4.
26. Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health 2000;21:171-92. (Pubitemid 30480321)
27. Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastro Hepatol 2007;5:921-31. (Pubitemid 47161142)
28. Armstrong D, Barnett E, Casper M, et al. Community occupational structure, medical and economic resources, and coronary mortality among US blacks and whites, 1980-1988. Ann Epidemiol 1998;8:184-91.
29. Liu CJ, Chuang WL, Lee CM, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009;136:496-504.
30. Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004;41:659-66.
31. Merlo J, Chaix B, Ohlsson H, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 2006;60:290-7.
32. Merlo J, Chaix B, Yang M, et al. A brief conceptual tutorial on multilevel analysis in social epidemiology: interpreting neighbourhood differences and the effect of neighbourhood characteristics on individual health. J Epidemiol Community Health 2005;59:1022-8. (Pubitemid 41728264)
33. Merlo J, Yang M, Chaix B, et al. A brief conceptual tutorial on multilevel analysis in social epidemiology: investigating contextual phenomena in different groups of people. J Epidemiol Community Health 2005;59:729-36. (Pubitemid 41176187)
34. Larsen K, Merlo J. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression [see comment]. Am J Epidemiol 2005;161:81-8.
35. Browne W. MCMC estimation in MLwiN version 20. London, UK: Centre for Multilevel Modelling, Institute of Education, University of London, 2003;297.
36. Rasbash J, Steele F, Browne W. A user's guide to MLwiN, version 20 documentation vVersion 21e. London: Centre for Multilevel Modelling, Institute of Education, University of London, 2003.
37. Simmonds P. Viral heterogeneity of the hepatitis C virus. J Hepatol 1999;31:54-60. (Pubitemid 30002692)
38. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infectionea systematic review. JAMA 2007;297:724-32. (Pubitemid 46294562)
39. Dal Molin G, Ansaldi F, Biagi C, et al. Changing molecular epidemiology of hepatitis C virus infection in northeast Italy. J Med Virol 2002;68:352-6.
40. Shin HR, Kim JY, Kim JI, et al. Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. Br J Cancer 2002;87:314-18.
41. Akhtar S, Moatter T. Multilevel modeling of intra-household spread of hepatitis C virus infection, Karachi, Pakistan. Am J Trop Med Hyg 2007;76:446-9. (Pubitemid 351627735)
42. McMahon JM, Pouget ER, Tortu S. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis. J Infect Dis 2007;195:1572-81. (Pubitemid 46799214)
43. Tovo PA, Pembrey L, Newell ML, et al. A significant sex-but not elective cesarean sectione - effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005;192:1872-9. (Pubitemid 41681884)
44. Chen KT, Chen CJ, Fagot-Campagna A, et al. Tobacco, betel quid, alcohol, and illicit drug use among 13- to 35-year-olds in I-Lan, rural Taiwan: prevalence and risk factors. Am J Public Health 2001;91:1130-4. (Pubitemid 32574842)
45. Chiang SC, Chen CY, Chang YY, et al. Prevalence of heroin and methamphetamine male users in the northern Taiwan, 1999-2002: capture-recapture estimates. BMC Public Health 2007;7.